Laurel Wealth Advisors (North Carolina)’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18
Closed -$1.46K 447
2025
Q4
$1.46K Buy
+18
New +$1.55K ﹤0.01% 622
2025
Q2
Sell
-18
Closed -$1.51K 465
2025
Q1
$1.51K Hold
18
﹤0.01% 610
2024
Q4
$1.66K Hold
18
﹤0.01% 632
2024
Q3
$1.67K Buy
+18
New +$1.56K ﹤0.01% 595

Other funds holding LMAT

Laurel Wealth Advisors (North Carolina)'s LMAT Position: Q1 2026 in Review

Laurel Wealth Advisors (North Carolina) sold out of LeMaitre Vascular (LMAT) in Q1 2026, closing a stake of 18 shares — an estimated $1.46K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in LMAT in Q3 2024 and held it in 4 quarters. The position peaked at $1.67K in Q3 2024. 340 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Laurel Wealth Advisors (North Carolina) reported no remaining LeMaitre Vascular position as of Q1 2026 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 18 LeMaitre Vascular shares in Q1 2026, an estimated $1.46K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in LeMaitre Vascular in Q3 2024 and held it in 4 quarters.
  • Laurel Wealth Advisors (North Carolina)'s LeMaitre Vascular position peaked at $1.67K in Q3 2024.
  • 340 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q1 2026, filed 13 May 2026.